Article

Kinases and Their Potential as Therapeutic Targets in Huntington’s Disease

2022-07-01

Abstract excerpt

Huntington’s Disease (HD) is a devastating neurodegenerative disorder caused by a CAG trinucleotide repeat expansion in the HTT gene, for which no disease modifying therapies are currently available. Much of the recent research has focused on developing therapies to directly lower HTT expression, and while promising, these therapies have presented several challenges regarding administration and efficacy. Ano...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c5bc7a86-897e-5c4b-9a5d-4fa50a2e00c2
DOI: 10.20944/preprints202207.0024.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Kinases and Their Potential as Therapeutic Targets in Huntington’s DiseaseDOI 10.20944/preprints202207.0024.v1Read

Protein Kinase CK2 and Its Potential Role as a Therapeutic Target in Huntington’s DiseaseSemantic proximity Read

Silmitasertib, an FDA-designated orphan CK2 Inhibitor, ameliorates neuropathology and motor dysfunction in a Huntington’s disease mouse modelSemantic proximity Read

TBK1 phosphorylates mutant Huntingtin and suppresses its aggregation and toxicity in Huntington's disease models.Semantic proximity Read

Implications of Tau Dysregulation in Huntington’s Disease and Potential for New TherapeuticsSemantic proximity Read

Suppression of MAPK11 or HIPK3 reduces mutant Huntingtin levels in Huntington's disease models.Semantic proximity Read

Identification of CK2α’ selective inhibitors by the screening of an allosteric-kinase-inhibitor-like compound librarySemantic proximity Read

CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disordersSemantic proximity Read

Therapeutics Advancement for Huntington DiseaseSemantic proximity Read

Therapeutic Advances for Huntington’s DiseaseSemantic proximity Read

CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington’s diseaseSemantic proximity Read

Protein kinase CK2: a potential therapeutic target for diverse human diseases.Semantic proximity Read

Targeting phosphatases as the next generation of disease modifying therapeutics for Parkinson's disease.Semantic proximity Read